Produkty 78916-25-3

CAS 78916-25-3 występuje w naszej ofercie pod nazwami: Cholesterol Isopropyl Carbonate, Cholesterol Isopropyl Carbonate, 95%, 95%, Cholesterol isopropyl carbonate, 95%. Oferty producentów: Biosynth, Chemat, Fluorochem. Dostępne opakowania: 25g, 10g, 50g, 1g.

Cholesterol Isopropyl Carbonate
Biosynth
  • opakowanie: 25g, 10g, 50g
  • Warianty: 3
Zobacz produkt
Cholesterol Isopropyl Carbonate, 95%, 95%
Chemat
  • opakowanie: 1g
  • Warianty: 1
od 141,20
Zobacz produkt
Cholesterol isopropyl carbonate, 95%
Fluorochem
  • opakowanie: 1g
  • Warianty: 1
od 216,61
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propan-2-yl carbonate (CAS 78916-25-3) to związek chemiczny o wzorze sumarycznym C31H52O3 i masie molowej 472.7 g/mol. Nazwa systematyczna IUPAC: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propan-2-yl carbonate. InChIKey: DFGCTZUMTALIQV-GTPODGLVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC31H52O3
Masa molowa472.7 g/mol
Nazwa IUPAC[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propan-2-yl carbonate
InChIKeyDFGCTZUMTALIQV-GTPODGLVSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)OC(C)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (3beta)-Cholest-5-en-3-yl propan-2-yl carbonate, Cholesterol Isopropyl Carbonate, Isopropyl Carbonic Acid Cholesterol Ester, DFGCTZUMTALIQV-GTPODGLVSA-N, Cholest-5-en-3beta-yl propan-2-yl carbonate
Izomery (ten sam wzór sumaryczny)
[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate C31H52O3
[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate C31H52O3
[4-methoxy-2,6-dimethyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)phenyl] acetate C31H52O3
[(2R,3R)-2,3,4,6,7-pentamethyl-2-(4,8,12-trimethyltridecyl)-3H-1-benzofuran-5-yl] acetate C31H52O3
[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] dodecanoate C31H52O3
[(3S,8S,9S,10R,13R,14S)-17-[(2R,4R,5S)-5-ethyl-4-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C31H52O3
[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate C31H52O3
[(2R)-2,8-dimethyl-5,7-bis(trideuteriomethyl)-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate C31H52O3
[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] 2,2,2-trideuterioacetate C31H52O3
(5R,8R,9R,10R,13R,14R,17S)-17-[(2S,6S)-6-methoxy-2,5,5-trimethyloxan-2-yl]-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C31H52O3
(3S,4S,4aR,6aR,6bS,8aR,9R,14aR,14bR)-4-(hydroxymethyl)-9-methoxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-ol C31H52O3
(3S,7S,8R,9S,10S,13R,14S,17R)-17-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C31H52O3